Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Soleno Therapeutics Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −8 vs. Q2 2021
- Shares held
- 29.4M
- −213.7K (−0.7%) vs. Q2 2021
- Total value
- $27.1M
- −$6.49M (−19.3%) vs. Q2 2021
- New holders
- 5
- 9 more added
- Sold out
- 13
- 10 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 227 | $2.09B |
| Q4 2025 | 248 | $3.01B |
| Q3 2025 | 240 | $4.41B |
| Q2 2025 | 234 | $4.75B |
| Q1 2025 | 217 | $3.90B |
| Q4 2024 | 166 | $2.29B |
| Q3 2024 | 142 | $2.38B |
| Q2 2024 | 114 | $1.79B |
| Q1 2024 | 98 | $1.52B |
| Q4 2023 | 76 | $1.26B |
| Q3 2023 | 54 | $598.8M |
| Q2 2023 | 23 | $21.8M |
| Q1 2023 | 21 | $7.06M |
| Q4 2022 | 26 | $6.00M |
| Q3 2022 | 22 | $5.23M |
| Q2 2022 | 40 | $8.80M |
| Q1 2022 | 41 | $11.2M |
| Q4 2021 | 39 | $11.8M |
| Q3 2021 | 39 | $27.1M |
| Q2 2021 | 47 | $33.6M |
| Q1 2021 | 63 | $41.2M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Soleno Therapeutics Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 594 | $0 | 0.00% | −10,059−94.4% | Reduced |
| Royal Bank of Canada | 282 | $0 | 0.00% | −3,601−92.7% | Reduced |
| JPMorgan Chase & Co | 95 | $0 | 0.00% | −2,925−96.9% | Reduced |
| Wells Fargo & Company | 347 | $0 | 0.00% | −7−2.0% | Reduced |
| Cutler Group LP | 1,100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bray Capital Advisors | 2,000 | $2.00K | 0.00% | +2,000 | New |
| Advisor Group Holdings, Inc. | 3,040 | $3.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 6,822 | $6.00K | 0.00% | +237+3.6% | Added |
| Levy Wealth Management Group, LLC | 10,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 10,400 | $10.0K | 0.00% | −363,785−97.2% | Reduced |
| Avantax Planning Partners, Inc. | 10,700 | $10.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 12,154 | $11.0K | 0.00% | −768−5.9% | Reduced |
| PEAK6 Investments LLC | 12,388 | $11.0K | 0.00% | +12,388 | New |
| Group One Trading, L.P. | 13,030 | $12.0K | 0.00% | −5,300−28.9% | Reduced |
| UBS Group AG | 16,306 | $15.0K | 0.00% | +15,344+1,595.0% | Added |
| Migdal Insurance & Financial Holdings Ltd. | 17,524 | $16.0K | 0.00% | +17,524 | New |
| Aspiriant, LLC | 17,295 | $16.0K | 0.00% | +17,295 | New |
| Warberg Asset Management LLC | 30,000 | $28.0K | 0.01% | 00.0% | Unchanged |
| Bollard Group LLC | 34,322 | $32.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 42,270 | $39.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 37,747 | $42.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 74,525 | $69.0K | 0.00% | −196,175−72.5% | Reduced |
| Susquehanna International Group, LLP | 105,893 | $97.0K | 0.00% | −7,093−6.3% | Reduced |
| Northern Trust Corp | 105,481 | $97.0K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 121,694 | $112.0K | 0.03% | −768−0.6% | Reduced |
| BlackRock Inc. | 129,773 | $120.0K | 0.00% | +116,378+868.8% | Added |
| BNP Paribas Arbitrage, SA | 140,346 | $129.8K | 0.00% | +81+0.1% | Added |
| Citadel Advisors LLC | 157,951 | $146.0K | 0.00% | +13,073+9.0% | Added |
| State Street Corp | 220,100 | $203.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 365,846 | $338.0K | 0.00% | +147,594+67.6% | Added |
| Geode Capital Management, LLC | 430,253 | $397.0K | 0.00% | +18,185+4.4% | Added |
| Oppenheimer & Co Inc | 639,140 | $591.0K | 0.01% | +5,569+0.9% | Added |
| Granite Point Capital Management, L.P. | 701,838 | $649.0K | 0.25% | +701,838 | New |
| Two Sigma Advisers, LP | 744,000 | $688.0K | 0.00% | +339,900+84.1% | Added |
| Birchview Capital, LP | 876,899 | $811.0K | 0.55% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,068,512 | $1.91M | 0.00% | 00.0% | Unchanged |
| Oracle Investment Management Inc | 2,132,000 | $1.97M | 0.25% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 9,765,129 | $9.03M | 0.53% | 00.0% | Unchanged |
| Abingworth LLP | 10,302,602 | $9.50M | 2.16% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −299,074−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −298,700−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −194,965−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −109,382−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −24,975−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −19,219−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −19,500−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −18,388−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −14,361−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −13,574−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −11,011−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −6,996−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −528−100.0% | Sold out |